Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice
- 15 December 2005
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (2) , 371-374
- https://doi.org/10.1038/sj.leu.2404056
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Immunotherapy of cancer through targeting of minor histocompatibility antigensCurrent Opinion in Immunology, 2005
- Human Telomerase Reverse Transcriptase-Transduced Human Cytotoxic T Cells Suppress the Growth of Human Melanoma in Immunodeficient MiceCancer Research, 2004
- Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaProceedings of the National Academy of Sciences, 2003
- Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cellsProceedings of the National Academy of Sciences, 2002
- An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid miceBlood, 2002
- CD8+minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cellsProceedings of the National Academy of Sciences, 1999
- Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo–Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility AntigensBlood, 1999